Metraipolis › archive › dc_84e7df583363

Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer — Europe PMC PMID:41221278

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41221278
DOI
10.3389/fimmu.2025.1656593
License (as archived)
solo-consultazione
Archived
2026-11-09T00:55:26.952Z
SHA-256 of the archived text
5e064d49a1a08d1605a15f0f9f30e62a0c6207401dcc7b811266b8852c424773
Stable URL of this page
https://metraipolis.com/documento/dc_84e7df583363

How to cite

Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer — Europe PMC PMID:41221278 — Europe PMC (en), https://europepmc.org/article/MED/41221278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_84e7df583363 (Metraipolis archive dc_84e7df583363, sha256 5e064d49a1a08d1605a15f0f9f30e62a0c6207401dcc7b811266b8852c424773)
BibTeX
@misc{dc84e7df583363,
  title = {Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer — Europe PMC PMID:41221278},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41221278},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_84e7df583363; sha256 5e064d49a1a08d1605a15f0f9f30e62a0c6207401dcc7b811266b8852c424773},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41221278. Agents can read the archived copy with the MCP tool read_document.